ACTIVE HALF-LIFE
8-9 hours
CLASSIFICATION
Anabolic Steroid
DOSAGE
Men: 250-350mg/week
ACNE
Yes
WATER RETENTION
High
HBR
Possible
HEPATOTOXICITY
Yes
AROMATIZATION
No
CARRIER OIL
Grapeseed Oil
MANUFACTURER
Pharmacom Labs
LAB TEST
Refer to Document
WAREHOUSE
International Warehouse 3
SUBSTANCE
Oxymetholone Injectable
Introducing Oxymetholone, also known as Anapolon or Anadrol, a potent anabolic steroid and a 17-alpha-alkylated derivative of dihydrotestosterone. Initially developed to combat osteoporosis and anemia, this steroid boosts muscle growth in individuals with nutritional deficiencies or weakened conditions. The FDA has approved oxymetholone for human use; however, its popularity waned with the rise of effective non-steroidal alternatives, leading to its production halt by Syntex in 1993 and other manufacturers.
When it comes to performance, oxymetholone mirrors the effects of methandienone, delivering impressive muscle gains along with significant strength enhancements. A considerable portion of the weight gained is due to water retention, which may increase blood pressure during your cycle.
One of the standout features of oxymetholone is its ability to elevate hemoglobin levels and boost overall blood volume, resulting in an intense "pump" effect during workouts. This can make training more challenging, as muscles may feel sore shortly after heavy lifting.
As a derivative of dihydrotestosterone, oxymetholone boasts a chemical structure that does not undergo aromatization, meaning it doesn't convert to estradiol. However, it does exhibit notable estrogenic properties, so it's essential to use antiestrogens to mitigate any potential side effects, as aromatase inhibitors won?t be effective.
While some suggest that oxymetholone's estrogenic effects may be linked to progestogenic activity, similar to nandrolones, clinical studies have shown that it does not exhibit such characteristics.
Pharmacom Labs has crafted an injectable version of this steroid, providing enhanced bioavailability and reduced hepatotoxicity compared to oral administration, as it bypasses the liver's first-pass metabolism.